Abstract
We here report on a case of a 46-year-old male under evaluation for persistent long-term (for more than 20 years) Hypertriglyceridemia (HTG) submitted to us for a genomic study based in an exome analysis of a mixed dyslipidemia, with Hypercholesterolemia (HC) and HTG (in multiple serum determinations, in recent years on Abbott Alinity Chemistry Analyzers), with unequal response to treatment (with statins for HC, and fibrates for HTG), with a progressive decrease in cholesterol values (now at almost optimal values of LDL cholesterol, around 125 mg/dL) while with no effect on TGs measurements (commonly around 600 mg/dL).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Biomedical Research & Environmental Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
